Valproic acid induced pancreatitis: Case report
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Pediatric pancreatitis was previously considered a rare disease. Currently, 13.2 cases are reported per 100,000 children/year. The most important cause of pancreatitis in the pediatric population, after biliary etiology, are medications (13% of cases). One of the main medications as a cause of pediatric pancreatitis is valproic acid (VA), which can lead to acute pancreatitis. Here we will present the first case of VA pancreatitis in the pediatric population reported in Colombia. This is a four-year-old patient, with a neurodevelopmental disorder due to TORCH syndrome, who was taking VA long-term for a conduct disorder. He was admitted to a highly complex institution where acute pancreatitis was diagnosed with signs of necrosis in pancreatic tissue secondary to the use of VA. The medication was discontinued with resolution of his set of symptoms and medical discharge around day 15.
Article Details
References
Uc A, Fishman DS. Pancreatic disorders. Pediatric Clinics of North America. 2017;64(3):685–706.
Nydegger A, Heine RG, Ranuh R. Changing incidence of acute pancreatitis: 10-year experience at the Royal Children’s Hospital, Melbourne. J Gastroenterol Hepatol. 2007;22:1313-6.
Pohl JF, Uc A. Paediatric pancreatitis: Current Opinion in Gastroenterology. 2015;31(5):380–6.
Shukla-Udawatta M, Madani S, Kamat D. An update on pediatric pancreatitis. Pediatr Ann. 2017;46(5):e207–11.
Mark R, Jones BA. Drug-induced acute pancreatitis: A review. The Ochsner Journal. 2015;15:45– 51.
Doyon S. Anticonvulants in: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank,s toxicologic emergencies Ed McGraw-Hill. 11ThEdition, 2017.
Gunaydin YK, Akilli NB, Dundar ZD, Koylu R, Sert ET, Cekmen B, Akinci E, Cander B, Antiepileptic drug poisoning: Three-year experience.Toxicology Reports. 2015;23:56–62.
Ztajnkrycer MD. Valproic acid toxicity: Overview and management. Toxicol Clin Toxicol. 2002;40(6):789-801.
Berrouet MC, Zuluaga M, Estrada AF, Diaz J, Gonzalez S. Utilidad de la hemodiálisis en intoxicación por antionvulsivantes: reporte de dos casos Revista de Toxicología. 2019;36(2):113- 9.
McNamara JO. Pharmacotherapy of the epilepsies. In: Brunton LL, Chabner BA, Knollmann BC (eds.). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 12e New York, NY: McGraw-Hill. 2017.
Cofini M, Quadrozzi F, Favoriti P, Favoriti M, Cofini G. Valproic acid-induced acute pancreatitis in pediatric age: Case series and review of literature. G Chir. 2015;36(4):158-60.
Batalden PB, Van Dyne BJ, Cloyd J. Pancreatitis associated with-valproic acid therapy. Pediatrics. 1979;64:520–22.
Gerstner T, Büsing D, Bell N, Longin E, Kasper JM, Klostermann W, et al. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol. 2007;42(1):39-48.
Pawłowska-Kamieniak A, Krawiec P, Pac-Kożuchowska E. Acute pancreatitis as a complication of antiepileptic treatment: Case series and review of the literature. Pediatric Reports. 2021;13(1):98–103.